EphA3, an essential regulatory target of ADAM10 through cleaving its primary ligand ephrin-A5, is a member of the receptor tyrosine kinase family, and has been reported to have dual biological effects in tumor progression [16]. Here, EPHA3 is linked to neoplasm.